The risks of adverse events with venlafaxine for adults with major depressive disorder: a systematic review of randomised clinical trials with meta-analysis and Trial Sequential Analysis

• Main Authors: C. B. Kamp (Author), J. J. Petersen (Author), P. Faltermeier (Author), S. Juul (Author), F. Siddiqui (Author), J. Moncrieff (Author), M. A. Horowitz (Author), M. P. Hengartner (Author), I. Kirsch (Author), C. Gluud (Author), J. C. Jakobsen (Author)
• Format: Book
• Published: Cambridge University Press, 2024-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Aims Venlafaxine is used to treat depression worldwide. Previous reviews have demonstrated that venlafaxine lowers scores on depression rating scales, producing statistically significant results but the relevance to patients remains uncertain. Knowledge of the incidence of the adverse effec...